glp-1 mechanism of action animation Mechanisms and Therapeutic Application of Glucagon-like Peptide-1 Molecular Mechanism of Action of

GLP-1 therapy is a proven tool for weight management and metabolic health, but side effects can interfere with consistency

Ozempic is FDA approved, while compounded semaglutide isnt

When side effects occur, they are usually mild to moderate gastrointestinal symptoms (nausea, constipation, indigestion) and tend to ease as your body adjusts

Compounded semaglutide can cause nausea, vomiting, and appetite changes as your body adjusts to treatment

There is a growing call for policies to improve access to these potentially life-changing treatments

It regulates the secretion and sensitivity of insulin while suppressing glucagon secretion and decreasing postprandial glucose levels